Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7731582

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
50,758,000,000 JPY
115,373,000,000 JPY
54,628,000,000 JPY
Ordinary profit (loss)
1,693,000,000 JPY
10,874,000,000 JPY
3,921,000,000 JPY
Net assets
157,501,000,000 JPY
157,837,000,000 JPY
153,719,000,000 JPY
Total assets
189,993,000,000 JPY
192,668,000,000 JPY
188,285,000,000 JPY
Basic earnings (loss) per share
-15.66
16.86
99.45
1.42
36.56
Diluted earnings per share
Equity-to-asset ratio
0.829 xbrli:pure
0.819 xbrli:pure
0.816 xbrli:pure
Net cash provided by (used in) operating activities
7,260,000,000 JPY
16,386,000,000 JPY
14,514,000,000 JPY
Net cash provided by (used in) investing activities
-3,928,000,000 JPY
-13,142,000,000 JPY
-3,895,000,000 JPY
Net cash provided by (used in) financing activities
-2,685,000,000 JPY
-5,721,000,000 JPY
-4,114,000,000 JPY
Cash and cash equivalents
43,137,000,000 JPY
42,499,000,000 JPY
51,021,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.